The Surefire Medical Blog

Clinical news, liver cancer topics, technology updates and Surefire Medical events.

Blog Test

Default post description

The Latest

Clinical News

Retrospective Clinical Study Shows Surefire Medical Provides 91% Response Rate After Single Treatment

Clinical News

Clinical Data Shows Surefire Provides 80% Complete Response Rate

Clinical Data Shows Surefire Technology Provides 80% Complete Response Rate for Bridge-to-Transplant Primary Liver Cancer Treatment versus 52% for Standard Microcatheter

Clinical News

Grant Received to Pursue Phase 1b Clinical Trial of CAR-T Immunotherapy Delivery

Surefire to Collaborate with Roger Williams Medical Center and University of Colorado School of Medicine

Clinical News

Surefire Technology Results in 92% Objective Response Rate

Surefire Precision Infusion System was associated with a 68 percent complete tumor response and 92 percent objective tumor response